Columnistas Expertos Expert Columnists

SIIC publica artículos originales e inéditos escritos por prestigiosos investigadores, expresamente invitados.

SIIC publishes original and novel manuscripts written by prestigious researchers who have been specially invited.

Giuseppe Patti
Assistant Professor of Cardiology; Chief of Instrumental Cardiology Division

Artículos publicados
(selección):
DEMUESTRAN LOS BENEFICIOS DEL USO DE ALTAS DOSIS DE CLOPIDOGREL DESPUéS DE UNA ANGIOPLASTIA CORONARIA
Entrevista exclusiva a Giuseppe Patti

Primera edición en siicsalud: 6 de octubre, 2011
Sección Expertos Invitados, subsección Entrevistas,
página https://www.siicsalud.com/dato/ensiic.php/122799  
Especialidad principal: Especialidad principalCardiología
Especialidad principalFarmacología

Especialidades relacionadas:
Bioquímica,Cuidados Intensivos,Cirugía,Diagnóstico por Laboratorio,Geriatría,Hematología,Medicina Interna,

  • V. Pasceri, G Patti, A. Nusca, C. Pristipino, G. Richichi, G. Di Sciascio A Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention. Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplast-) study, Circulation 110:674-678, 2004

  • G Patti, V. Pasceri, R. Melfi, C. Goffredo, M. Chello, A. D'Ambrosio, R. Montesanti, G. Di Sciascio Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation, Circulation 11:70-75, 2005

  • G Patti, G Colonna, V Pasceri, L Lassandro Pepe, A Montinaro, G Di Sciascio A Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Peri-procedural Myocardial Infarction in Patients Undergoing Coronary Intervention Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study, Circulation 111:2099-2106, 2005

  • G Patti, M Chello, V Pasceri, D Colonna, A Nusca, M Miglionico, A D'Ambrosio, E Covino, G Di Sciascio. J Am Coll Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention. Results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) Substudy, Cardiol 48:1560-1566, 2006

  • G Patti, V Pasceri, G Colonna, M Miglionico, D Fischetti, G Sardella, A Montinaro, G Di Sciascio Atorvastatin Pretreatment Improves Outcome in Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention. Results of the ARMYDA-ACS (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Acute Coronary Syndromes) Randomized Trial, J Am Coll Cardiol 49:1272-1278, 2007

  • G Patti, A Nusca, F Mangiacapra, L Gatto, A D'Ambrosio, G Di Sciascio Point-of-care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention. Results of the ARMYDA-PRO (Antiplatelet Therapy for Reduction of MYocardial Damage During Angioplasty - Platelet Reactivity Predicts Outcome) Study, J Am Coll Cardiol 52:1128-1133, 2008

  • G Patti, A Nusca, G Di Sciascio Meta-analysis Comparison (Nine Trials) of Outcomes With Drug-Eluting Stents versus Bare Metal Stents in Patients With Diabetes Mellitus, Am J Cardiol 102:1328-1334, 2008

  • G Di Sciascio, G Patti, V Pasceri, A Gaspardone, G Colonna, A Montinaro Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary interventon: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Randomized Trial, J Am Coll Cardiol 54:558-565, 2009

  • DR Jr Holmes, DJ Kereiakes, NS Kleiman, DJ Moliterno, G Patti, CL Grines Combining antiplatelet and anticoagulant therapies, J Am Coll Cardiol 54:95-109, 2009

  • G Di Sciascio, G Patti, V Pasceri, G Colonna, F Mangiacapra, A Montinaro Clopidogrel Reloading in Patients Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy. Results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Randomized Trial, Eur Heart J 31:1337-1343, 2010

  • G Di Sciascio, G Patti, V Pasceri, L Gatto, G Colonna, A Montinaro Effectiveness of In-lab High Dose Clopidogrel Loading vs Routine Preload in Patients Undergoing Percutaneous Coronary Intervention. Results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Randomized Trial, J Am Coll Cardiol 56:550-557, 2010

  • G Patti, V Pasceri, V Vizzi, E Ricottini, G Di Sciascio Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (From the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-BLEEDing Study), Am J Cardiol :, 2011

  • Patti G, Ricottini E, Nusca A, Colonna G, Pasceri V, D'Ambrosio A, Montinaro A, Di Sciascio G Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Contrast-Induced Nephropathy] Trial, Am J Cardiol :, 2011


  • Dr.  Giuseppe Patti Los suscriptores, miembros de SIIC y socios del Círculo de Lectores pueden solicitar información adicional. Para enviarla, SIIC solicitará aprobación del autor.

    Dirección profesional:

    , Roma , , Italia



    anterior.gif (1015 bytes)